Objective: To observe the therapeutic effect of antihyperlipidemic decoction on hyperlipemia. Methods: 77 hyperlipemia patients are selected and randomly divided into two groups. 37 cases in the treatment group received the treatment of antihyperlipidemic decoction, and 40 cases in the control group received western medicine, zhinbiticose. The course of treatment for both groups was 8 weeks. Results: The difference in total effective rate between the two groups was significant (P<0.05). Conclusion: Antihyperlipidemic decoction has a better therapeutic effect for hyperlipemia, with a lower recurrence rate and less side effect.
The authors have treated 77 cases of hyperlipemia by antihyperlipidemic decoction (a self-prescribed formula for clearing blood-lipid by resolving phlegm and eliminating dampness, and activating blood and dispelling stasis) with a satisfactory result as reported in the following.
CLINICAL MATERIALS
All the patients were outpatients from the authors' hospital. According to the chapter of hyperlipemia in Practical Internal Medicine and the guiding principle on treatment of hyperlipemia in Guidelines of Clinical Research on New Drugs of Traditional Chinese Medicines, 1 the inclusive criteria were formulated: 1) blood lipid level were measured for two times within two weeks under regular diet, TC ≥5.72 mmol/L or TG ≥1.70 mmol/L, or male: HDL-C ≤1.04 mmol/L, female: HDL-C ≤1.17 mmol/L. 2) being up to diagnostic criteria of phlegm-damp and blood stasis syndrome in TCM: the main symptoms being dizziness or distention of the head, headache or numbness of extremities, accompanied by lumbar soreness and weakness, fatigue; thoracic oppression, shortness of breath; distending pain in the chest and hypochondrium, precordial stabbing pain; obesity, abdominal distention, poor appetite, etc; pale and enlarged tongue or tongue with petechiae, and soft-slippery pulse or wiry-slippery pulse.
All the patients who fitted in with the criteria of laboratory findings and had above two items of the main symptoms of TCM as well as one group of accompanied symptoms could be included. All the patients with nephritic syndrome, hypothyroidism, diabetes and secondary hyperlipemia due to other diseases were excluded from this series.
All the 77 cases were randomly divided into two groups. Of them, 37 cases were in the treatment group and 40 cases in the control group. There were no significant differences in sex, age, duration of illness, BMI, the blood-lipid level before treatment (Table 1) . were decocted in water. The decoction was orally administered to the patients in the treatment group one dose per day in equally divided portions (150 ml each time twice daily). Zhinbiticose was orally administered to the patients in the control group, 1.05g each time, three times daily. 8-week was one therapeutic course for the two groups. The patients were advised to keep the usual pattern of daily life and routine food habits and withhold any drug which might affect the blood lipid metabolism.
Observation methods
Blood samples were intravenously drawn in the fasting state to measure TC, TG, LDL-C, Apo-B, HDL-c and Apo-A before treatment and 8 weeks after treatment with Olympus auto-biochemical analyzer.
The results of laboratory findings were expressed as mmol/L. Body mass index (BMI) was measured at the same time.
The functions of the liver and kidney, routine tests of blood and urine and ECG were examined before and after treatment for the two groups.
The above indices were re-checked to observe the recurrence rate after withdrawing drug for 3 months.
Therapeutic criteria
The therapeutic standards for hyperlipemia in
Guidelines of Clinical Research on New Drugs of
Traditional Chinese Medicines were adopted in evaluation of the therapeutic effects. Markedly improved: the changes in blood lipids reached any item of the followings, TC decreased by ≥20%, TG decreased by ≥40%, HDL-C increased by ≥0.26 mmol/L, and TC-HDL-C/HDL-C decreased by ≥20%; Improved: the changes in blood lipids reached any item of the followings, TC decreased by ≥10% but <20%, TG decreased by ≥20% but <40%, increasing of HDL-C increased by ≥0.104 mmol/L but <0.26 mmol/L; Failed: the changes in blood lipids did not reach the above criteria.
Side-effect
The side-effect was observed and recorded during the administration of the drugs in the two groups.
Statistic methods
The data were analyzed statistically with SPSS statistic software.
RESULTS
The total effective rate in the treatment group was much better than that in the control group after 8-week treatment (Table 2 ). In the treatment group, TC, TG, LDL-C and BMI were significantly decreased (P<0.01) after treatment as compared to those before treatment, and the decrements of TC, TG in the treatment group were significantly higher than those in the control group (P<0.01). In the control group, LDL-C and BMI were significantly decreased (P<0.01) after treatment, but insignificant differences in TC and TG before and after treatment were seen ( Table 3 ).
The recurrence rate in the treatment group was much lower than that in the control group after withdrawing the drug for three months (Table 4) . No obvious sideeffect was found during administration of the drugs in the two groups. DISCUSSION Hyperlipemia is closely related with "phlegm" in traditional Chinese medicine. Phlegm is divided into internal and external phlegm. External phlegm is caused by over intake of fat and sweet food, producing dampness and phlegm while internal phlegm is caused by dysfunction of zang-fu organs, especially dysfunction of the spleen, resulting in disorder of transportation and transformation of water and food. When the functions of the zang-fu organs are affected, food overtaken or water can not be normally transported and transformed, leading to retention, and turning the retention into turbidity, fat into phlegm-damp, affecting the blood vessels, resulting in obstructed circulation of qi and blood, thus phlegm combined with blood stasis remain inside the vessels, which further injures the functions of the zang-fu organs, giving rise to the occurrence of this disease. Therefore, as the pathological products and pathogenic factors, phlegm and blood stasis are the key factors for the onset of hyperlipemia. Through clinical observation and lab research, modern experts think TC, TG, and LDL-C are the main features and biochemical material basis of hyperlipemia caused by phlegm. The objective property of the blood stasis is manifested by the abnormal changes of hemodynamics, microcirculation dysfunction and abnormal hemorheology. 3 So it is widely acknowledgeable that phlegm turbidity with stagnant blood is the main pathogenesis, which provides the objective basis for the treatment of hyperlipemia. Sheng Pu Huang (生 蒲 黄 Pollen Typhae), Sheng Shan Zha (生 山 楂 Fructus Crataegi) and Dan Shen (丹参 Radix Salviae Miltiorrhizae) have the functions of activating blood and resolving stasis to expel phlegm in the vessels; Ze Xie (泽泻 Rhizoma Alismatis) and Sheng Yi Yi Ren (生薏苡仁 Semen Coicis) can strengthen the spleen and remove dampness; Jue Ming Zi (决明子 Semen Cassias) clears heat and removes turbidity; Sheng Huang Qi (黄芪 Radix Astragali) that acts on the lung and spleen channels, combines with Sheng Pu Huang (生蒲黄 Pollen Typhae), Sheng Shan Zha (生山楂 Fructus Crataegi) and Dan Shen (丹参 Radix Salviae Miltiorrhizae), which may tonify qi to promote blood circulation, strengthen the function of activating blood and removing blood stasis. The formula may resolve phlegm and remove blood stasis, turbidity and lipid, and treat the symptoms as well as the root cause of the disease. Researches indicate that Huang Qi (黄芪 Radix Astragali ) has the function of adjusting blood-lipid of the mice and improve the ability of antioxidation. 4 Pu Huang (蒲黄 Pollen
Typhae) was applied to feed the quails with hyperlipemia through the stomach and the level of TC and TG greatly decreased. 5 Jue Ming Zi (决明子 Semen Cassias) may significantly increase the content of HDL-C, improve the ratio of HDL-C and TC and improve TC distribution inside the body. 6 Clinical researches indicate that therapeutic effect of antihyperlipidemic decoction on hyperlipemia of phlegm-turbidity and blood stasis is reliable and satisfactory, with no side-effect and low recurrence rate. Further research is expected to be carried out.
